PFM
CRXTW

Privium Fund Management’s Clarus Therapeutics Holdings, Inc. Warrants CRXTW Stock Holding History

Privium Fund Management’s Portfolio CRXTW Stock Details CRXTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-163,030
Closed -$13K – 290
2022
Q2 		$13K Buy
+163,030
New +$16K ﹤0.01% 162
2022
Q1 		– Sell
-163,030
Closed -$42K – 313
2021
Q4 		$42K Buy
+163,030
New +$83.3K 0.01% 151

Other funds holding CRXTW

MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return